Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation Read more
UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer Read more
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD) Read more
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology Read more
Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application (sNDA) for REXULTI (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease Read more
FDA accepts application for Roche’s Vabysmo for the treatment of retinal vein occlusion (RVO) Read more
AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN’S DISEASE Read more
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next Generation Sequencing-Based Testing for Cancer Patients in International Markets Read more
CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK Read more